◂ Announcements

Dec 29, 2023ACQUISITIONSwitzerland

Roche to acquire LumiraDx's Point of Care technology

Roche announced a definitive agreement to acquire select parts of the LumiraDx group related to its Point of Care technology for a purchase price of USD 295 million plus up to USD 55 million. The transaction is expected to close by mid-2024.

Value

$295.0M

Status

Announced

ProductsPoint of Care diagnostic technologyimmunoassay testsclinical chemistry tests

CompaniesRoche Holdings Inc acquirer LumiraDx target

Sectors#Medical Devices

“Roche announced today the entry into a definitive agreement to acquire select parts of the LumiraDx group related to LumiraDx’s innovative Point of Care technology.”globenewswire.com

1 source
globenewswire.comRoche enters into a definitive agreement to acquireF. Hoffmann-La Roche LtdDec 29, 2023

Summarized from public sources; check the original articles before acting on it.

More from Roche Holdings Inc

profile ▸

Loading…